A detailed history of Hrt Financial LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 12,944 shares of PTCT stock, worth $584,292. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,944
Holding current value
$584,292
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.39 - $37.66 $393,368 - $487,471
12,944 New
12,944 $480,000
Q4 2023

Feb 09, 2024

BUY
$18.07 - $29.37 $132,091 - $214,694
7,310 New
7,310 $201,000
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $881,361 - $1.13 Million
21,060 New
21,060 $1.06 Million
Q1 2019

May 14, 2019

SELL
$28.09 - $39.49 $284,804 - $400,389
-10,139 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$29.83 - $46.51 $302,446 - $471,564
10,139 New
10,139 $347,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.23B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.